Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia | MicrobiomeTrials← Back to trialsNCT07512687
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional Hypoxemia
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2026-09-02Est. Completion: 2027-10
Enrollment target: 24 participants Locations- State University of New York at Buffalo Jacobs School of Medicine and Biomedical Sciences, Buffalo, New York, United States
Other microbiome trials you might be interested in
Systemic SclerosisScleroderma
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…
Scottsdale, United StatesEst. completion Jan 6, 2027
Allogeneic Stem Cell TransplantationLung Allograft TransplantationInterstitial Lung DiseaseAcute Lung InjuryPulmonary Arterial HypertensionCardiovascular Diseases
Background:
Injury or diseases of the heart and lung can sometimes cause scar tissue (fibrosis) to build up in those or…
Bethesda, United StatesEst. completion May 26, 2031
Cystic FibrosisPulmonary FibrosisTuberous SclerosisAsthmaPulmonary Sarcoidosis
This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved …
Bethesda, United States